Where is Abbott Laboratories's operating cash flow disclosed?
The figure, the filing and period it comes from, and the reported definition.
The answer
$9.57B
Operating cash flow, fiscal year ending Dec 31, 2025
Document: 10-K filed 2026-02-20 (accession 0001628280-26-010185)
Reported as XBRL element NetCashProvidedByUsedInOperatingActivities (Net Cash Provided by (Used in) Operating Activities).
Definition: Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Calculation: none — the value is reported directly.
Source register
| Period end | Value | Form | Filed | Accession |
|---|---|---|---|---|
| Dec 31, 2018 | $6.30B | 10-K | 2021-02-19 | 0001104659-21-025751 |
| Dec 31, 2019 | $6.14B | 10-K | 2022-02-18 | 0001104659-22-025141 |
| Dec 31, 2020 | $7.90B | 10-K | 2023-02-17 | 0001628280-23-004026 |
| Dec 31, 2021 | $10.53B | 10-K | 2024-02-16 | 0001628280-24-005348 |
| Dec 31, 2022 | $9.58B | 10-K | 2025-02-21 | 0001628280-25-007110 |
| Dec 31, 2023 | $7.26B | 10-K | 2026-02-20 | 0001628280-26-010185 |
| Dec 31, 2024 | $8.56B | 10-K | 2026-02-20 | 0001628280-26-010185 |
| Dec 31, 2025 | $9.57B | 10-K | 2026-02-20 | 0001628280-26-010185 |